Single Molecule Approach to Neurodegeneration in Alzheimer's Disease

单分子方法治疗阿尔茨海默病神经退行性疾病

基本信息

  • 批准号:
    7729850
  • 负责人:
  • 金额:
    $ 53.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-15 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

Oligomers formed by the amyloid beta peptide, A-beta, have been shown to be neurotoxic, potently permeabilize biological membranes and are believed to be critical players in Alzheimers disease (AD). Applying traditional approaches to study these oligomers and the origin of their toxicity is challenging because ensemble averaging masks low amounts of transient intermediates and hinders the resolution of species heterogeneity especially when bound to membranes. In this two year ARRA supported project we propose to apply novel approaches based on single molecule microscopy (SMM), that are uniquely suited for these studies, to focus on the interactions between A-beta and neuronally-derived membranes to address the following specific aims: Aim 1: To determine the time evolution of A-beta oligomers in solution and identify the oligomers that bind to neuronal membranes and permeabilize them. We will characterize the interactions between solution-generated A-beta oligomeric species and membrane preparations made from brain extracted lipids as well as membrane patches excised from neuronal cells. These measurements will test the hypothesis that at elevated peptide concentrations, toxic oligomers form directly in solution and bind to and permeabilize the membrane without the need for additional growth. Aim 2: To determine the mechanism of Abeta oligomer assembly on the surface of membranes from neuronal cells, characterize the size of the oligomers at the onset of permeabilization and follow their subsequent evolution. Work on this Aim will allow us to: a) determine the effect of the native membrane environment on the oligomer assembly process and on the permeabilization power of these oligomers (relative to the solution generated oligomers in aim 1); b) determine how the membrane facilitates the formation of toxic oligomers at the low physiological concentrations of A-beta. One of the major missions of the ARRA funding is the creation of new jobs and the retention of current ones. In this request the additional support will be used to speed up the tempo of research, and will allow us to create three new positions (two GSRA and one postdoctoral) and to retain two experienced researchers who would otherwise be laid off.
淀粉样β肽(a - β)形成的低聚物已被证明具有神经毒性,可渗透生物膜,并被认为是阿尔茨海默病(AD)的关键因素。应用传统的方法来研究这些低聚物及其毒性的起源是具有挑战性的,因为集合平均掩盖了少量的瞬态中间体,阻碍了物种异质性的分解,特别是当结合到膜上时。在这个为期两年的ARRA支持的项目中,我们建议应用基于单分子显微镜(SMM)的新方法,这是唯一适合于这些研究的方法,专注于a - β和神经元衍生膜之间的相互作用,以解决以下具体目标:目标1:确定溶液中a - β低聚物的时间演变,并确定与神经元膜结合并使其渗透的低聚物。我们将描述溶液生成的a - β寡聚物与由脑提取脂质制成的膜制剂以及从神经元细胞中切除的膜斑块之间的相互作用。这些测量将测试假设,即在肽浓度升高时,有毒低聚物直接在溶液中形成,并结合并渗透膜,而不需要额外的生长。目的2:确定Abeta低聚物在神经细胞膜表面组装的机制,表征低聚物在渗透开始时的大小,并跟踪其随后的进化。在这个目标上的工作将使我们能够:a)确定天然膜环境对低聚物组装过程和这些低聚物的渗透能力的影响(相对于目标1中产生的低聚物的溶液);b)确定在低生理浓度的a - β下,膜如何促进有毒低聚物的形成。ARRA资金的主要任务之一是创造新的就业机会并保留现有的就业机会。在这项申请中,额外的支持将用于加快研究的节奏,并允许我们创建三个新职位(两个GSRA和一个博士后),并保留两个经验丰富的研究人员,否则他们将被解雇。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARI GAFNI其他文献

ARI GAFNI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARI GAFNI', 18)}}的其他基金

A Single Molecule Study of Amyloid Beta Neuronal Toxicity
β淀粉样蛋白神经元毒性的单分子研究
  • 批准号:
    7777812
  • 财政年份:
    2009
  • 资助金额:
    $ 53.7万
  • 项目类别:
Single Molecule Approach to Neurodegeneration in Alzheimer's Disease
单分子方法治疗阿尔茨海默病神经退行性疾病
  • 批准号:
    7930613
  • 财政年份:
    2009
  • 资助金额:
    $ 53.7万
  • 项目类别:
Michigan Molecular Biophysics Training Program
密歇根分子生物物理学培训计划
  • 批准号:
    7902701
  • 财政年份:
    2009
  • 资助金额:
    $ 53.7万
  • 项目类别:
A Single Molecule Approach to neurodegeneration in AD
治疗 AD 神经变性的单分子方法
  • 批准号:
    7267949
  • 财政年份:
    2006
  • 资助金额:
    $ 53.7万
  • 项目类别:
Single Molecule Studies of IAPP Oligomer Formation and Membrane Permeabilization
IAPP 寡聚物形成和膜透化的单分子研究
  • 批准号:
    7230068
  • 财政年份:
    2006
  • 资助金额:
    $ 53.7万
  • 项目类别:
Single Molecule Studies of IAPP Oligomer Formation and Membrane Permeabilization
IAPP 寡聚物形成和膜透化的单分子研究
  • 批准号:
    7074118
  • 财政年份:
    2006
  • 资助金额:
    $ 53.7万
  • 项目类别:
A Single Molecule Approach to neurodegeneration in AD
治疗 AD 神经变性的单分子方法
  • 批准号:
    7142101
  • 财政年份:
    2006
  • 资助金额:
    $ 53.7万
  • 项目类别:
PROTEIN CONFORMATION
蛋白质构象
  • 批准号:
    6593393
  • 财政年份:
    2002
  • 资助金额:
    $ 53.7万
  • 项目类别:
BIOCHEMISTRY CORE
生物化学核心
  • 批准号:
    6480655
  • 财政年份:
    2002
  • 资助金额:
    $ 53.7万
  • 项目类别:
PROTEIN CONFORMATION
蛋白质构象
  • 批准号:
    6458989
  • 财政年份:
    2001
  • 资助金额:
    $ 53.7万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 53.7万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 53.7万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.7万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.7万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 53.7万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.7万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 53.7万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 53.7万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 53.7万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.7万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了